Skip to main content
Hospitals, Healthtech & Pharmaceuticals

Security for patient trust.

Patient records, telemedicine flows, hospital networks, medical-IoT, and pharma R&D — every surface where the data is sensitive and the obligation is dual (privacy and safety). DPDP-aligned, HIPAA-aware, CERT-In empanelled since 2008.

65+
Healthcare Engagements
PHI-aware
Methodology
DPDP + HIPAA
Aligned
Since 2008
CERT-In Empanelled

The Challenge

Why healthcare and pharma need specialised security testing

Healthcare's threat model is dual — privacy (patient data) and safety (medical-IoT, e-prescription). Generic VAPT misses the nuances of PHI handling, hospital-LAN segmentation with clinical IoT, and pharma R&D IP protection.

PHI / Patient-Record Protection

Hospitals, diagnostic chains, and health-tech platforms hold electronic health records, lab results, prescriptions, and insurance-claim data — material under DPDP Act and HIPAA (for cross-border / US-customer-facing operations). A breach is reportable, costly, and brand-damaging in a sector where trust is central.

Telemedicine & E-Prescription Auth

Telehealth, e-prescription, and remote-monitoring platforms expose authentication and authorisation paths that scale with patient volume. OTP relay, prescription-form tampering, multi-tenant doctor / patient-record isolation, and consent-form abuse are real risks that scanners cannot see.

Medical-Device IoT Exposure

Hospital networks now include connected medical devices — infusion pumps, monitors, imaging systems, lab analysers — most running outdated firmware and rarely segmented from the corporate LAN. These are safety-critical IoT systems with the same OT testing posture as industrial SCADA: passive-by-default, segmentation-focused.

Pharma Supply Chain & R&D IP

Pharmaceutical R&D, clinical-trial data, and manufacturing process know-how are high-value targets for state-actor and competitor-funded groups. Code-review of LIMS / clinical-trial-management platforms, dark-web monitoring of researcher credentials, and red-team simulation of insider risk are the appropriate controls.

Services for Healthcare

Security tests calibrated to clinical and pharma reality

Each service is scoped with PHI-handling rigour, clinical-IoT caution, and trial-data confidentiality built in. Reports formatted for the auditor or regulator who will read them.

Compliance

Frameworks that matter to healthcare and pharma

We map findings to the specific clauses your auditor, HIPAA covered-entity-counsel, NABH inspector, or pharma sponsor-DPA will check — DPDP, HIPAA, GDPR, ISO 27001, ISO 27799 specifically for health.

Who We Work With

Trusted across hospitals, healthtech, and pharma

Brands listed below are current or recent customers in the healthcare and life-sciences bucket. Engagement specifics stay confidential — what's shared is the identity, not the work.

CloudNine Hospitals

Maternity & Paediatrics

Pharmeasy

E-pharmacy & Diagnostics

Wave Health

Healthtech

Top Diagnostic Chain

Pathology Network

Tier-1 Pharma

Pharmaceuticals R&D
65+

Healthcare clients

PHI-aware

Patient-data methodology

Since 2008

CERT-In empanelled

DPDP + HIPAA

Audit-ready reporting

Test before the next compliance audit cycle.

Whether it's a HIPAA-aligned PHI audit, a hospital-LAN + medical-IoT segmentation review, a telemedicine platform pen test, or pharma R&D code review — talk to our healthcare-sector lead.